RUNX2 and ovarian carcinoma: In addition, downregulation of RUNX2 expression significantly inhibited cell proliferation, migration, and invasion of ovarian cancer cells [29].Specifically, RUNX2 has been reported to be regulated in ovarian cancer by miR-338-3p [30] and miR-23b [31].